Skip to main content
. Author manuscript; available in PMC: 2019 Feb 4.
Published in final edited form as: Cancer Chemother Pharmacol. 2014 Sep 3;74(5):955–967. doi: 10.1007/s00280-014-2569-7

Fig. 4.

Fig. 4

Simulated perifosine plasma concentration–time profile at dose level 3. A one-compartment linear model was applied. The solid line is predicted perifosine concentration–time profile in the presence of a loading dose. The dotted line is predicted perifosine concentration–time profile without a loading dose